Top Midday Gainers

MT Newswires Live10-24

Scienture (SCNX) reported Thursday the start of commercial sales and fulfillment of the first customer orders for an Arbli (losartan potassium) oral suspension, 10 milligrams per milliliter.

Shares more than doubled as intraday trading volume catapulted to over 575 million from a daily average of about 2.2 million.

Ventyx Biosciences (VTYX) shares soared 91% amid heavy trading after the company overnight said VTX3232 demonstrated significant reductions in cardiovascular risk factors in a trial in phase 2 in patients with obesity and cardiovascular risks.

Intraday trading volume soared to over 103 million shares from a daily average of roughly 1.3 million.

Garrett Motion (GTX) reported stronger-than-expected Q3 earnings and net sales and raised its cash dividend while adjusting full-year 2025 revenue guidance.

Shares jumped 21%, with more than 4.9 million intraday trading volume compared with a daily average of about 3.2 million.

Price: 1.35, Change: +0.77, Percent Change: +135.35

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2577419587?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-24 02:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577419587","market":"us","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> Scienture (SCNX) reported Thursday the start of commercial sales and fulfillment of the first customer orders for an Arbli (losartan potassium) oral suspension, 10 milligrams per milliliter.</p><p>Shares more than doubled as intraday trading volume catapulted to over 575 million from a daily average of about 2.2 million.</p><p><a href=\"https://laohu8.com/S/VTYX\">Ventyx Biosciences</a> (VTYX) shares soared 91% amid heavy trading after the company overnight said VTX3232 demonstrated significant reductions in cardiovascular risk factors in a trial in phase 2 in patients with obesity and cardiovascular risks.</p><p>Intraday trading volume soared to over 103 million shares from a daily average of roughly 1.3 million.</p><p><a href=\"https://laohu8.com/S/GTX\">Garrett Motion</a> (GTX) reported stronger-than-expected Q3 earnings and net sales and raised its cash dividend while adjusting full-year 2025 revenue guidance.</p><p>Shares jumped 21%, with more than 4.9 million intraday trading volume compared with a daily average of about 3.2 million.</p><p>Price: 1.35, Change: +0.77, Percent Change: +135.35</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-24 02:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Scienture (SCNX) reported Thursday the start of commercial sales and fulfillment of the first customer orders for an Arbli (losartan potassium) oral suspension, 10 milligrams per milliliter.</p><p>Shares more than doubled as intraday trading volume catapulted to over 575 million from a daily average of about 2.2 million.</p><p><a href=\"https://laohu8.com/S/VTYX\">Ventyx Biosciences</a> (VTYX) shares soared 91% amid heavy trading after the company overnight said VTX3232 demonstrated significant reductions in cardiovascular risk factors in a trial in phase 2 in patients with obesity and cardiovascular risks.</p><p>Intraday trading volume soared to over 103 million shares from a daily average of roughly 1.3 million.</p><p><a href=\"https://laohu8.com/S/GTX\">Garrett Motion</a> (GTX) reported stronger-than-expected Q3 earnings and net sales and raised its cash dividend while adjusting full-year 2025 revenue guidance.</p><p>Shares jumped 21%, with more than 4.9 million intraday trading volume compared with a daily average of about 3.2 million.</p><p>Price: 1.35, Change: +0.77, Percent Change: +135.35</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B19Z4B17.USD","symbol_name":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2577419587","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577419587","pubTimestamp":1761242579,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Scienture  reported Thursday the start of commercial sales and fulfillment of the first customer orders for an Arbli  oral suspension, 10 milligrams per milliliter.Shares more than doubled as intraday trading volume catapulted to over 575 million from a daily average of about 2.2 million.Ventyx Biosciences  shares soared 91% amid heavy trading after the company overnight said VTX3232 demonstrated significant reductions in cardiovascular risk factors in a trial in phase 2 in patients with obesity and cardiovascular risks.Intraday trading volume soared to over 103 million shares from a daily average of roughly 1.3 million.Garrett Motion  reported stronger-than-expected Q3 earnings and net sales and raised its cash dividend while adjusting full-year 2025 revenue guidance.Shares jumped 21%, with more than 4.9 million intraday trading volume compared with a daily average of about 3.2 million.Price: 1.35, Change: +0.77, Percent Change: +135.35","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B19Z4B17.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) ACC","IE00B7SZL793.SGD":"Legg Mason Royce - US Small Cap Opportunity A Acc SGD-H","GTX":"Garrett Motion Inc.","BK4167":"医疗保健技术","SCNX":"Scienture Holdings, Inc.","IE0031619046.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) INC","BK4007":"制药","IE00B66KJ199.SGD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY  \" A\" (SGD) ACC","VTYX":"Ventyx Biosciences, Inc.","BK4124":"机动车零配件与设备"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VTYX":1,"GTX":1,"SCNX":1},"content_text":"Scienture (SCNX) reported Thursday the start of commercial sales and fulfillment of the first customer orders for an Arbli (losartan potassium) oral suspension, 10 milligrams per milliliter.Shares more than doubled as intraday trading volume catapulted to over 575 million from a daily average of about 2.2 million.Ventyx Biosciences (VTYX) shares soared 91% amid heavy trading after the company overnight said VTX3232 demonstrated significant reductions in cardiovascular risk factors in a trial in phase 2 in patients with obesity and cardiovascular risks.Intraday trading volume soared to over 103 million shares from a daily average of roughly 1.3 million.Garrett Motion (GTX) reported stronger-than-expected Q3 earnings and net sales and raised its cash dividend while adjusting full-year 2025 revenue guidance.Shares jumped 21%, with more than 4.9 million intraday trading volume compared with a daily average of about 3.2 million.Price: 1.35, Change: +0.77, Percent Change: +135.35","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2577419587","isCrawlerRequest":true}